Back to LLY
Kimelman & Baird, LLC LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
6
Latest value
$46.8M
Q3 2026
Peak value
$48.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $33.4M |
| Q4 2025 | $45M |
| Q1 2026 | $37.1M |
| Q2 2026 | $48.4M |
| Q2 2026 | $48.4M |
| Q3 2026 | $46.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $46.8M | 40.5K | — | — |
| Q2 2026 | $48.4M | 40.4K | — | — |
| Q2 2026 | $48.4M | 40.4K | — | — |
| Q1 2026 | $37.1M | 40.3K | — | — |
| Q4 2025 | $45M | 41.9K | — | — |
| Q3 2025 | $33.4M | 43.7K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B